SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-021026
Filing Date
2021-04-09
Accepted
2021-04-09 16:16:00
Documents
1
Period of Report
2021-04-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3422
  Complete submission text file 0001213900-21-021026.txt   4805
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 DURHAM TERRACE LONDON X0 W25PB
Business Address
Feldmann Marc (Reporting) CIK: 0001832327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 21818026